Skip to main content

Market Overview

Why Change Healthcare, Isoray And Alkido Are Moving Today

Share:
Why Change Healthcare, Isoray And Alkido Are Moving Today

Alkido Pharma (NASDAQ: AIKI) shares are trading higher after the company announced it executed a Patent License Agreement for technology that covers the use of psilocybin for cancer applications.

AIkido Pharma is engaged in the development of small-molecule anti-cancer therapeutics.

Alkido Pharma shares were trading up 41.92% at $1.21. The stock has a 52-week high of $5.52 and a 52-week low of 47 cents.

Change Healthcare (NASDAQ: CHNG) shares are trading higher after the company announced it will be acquired by United Health's OptumInsight for $25.75 per share in cash.

Change Healthcare is a spin-off of various healthcare processing and consulting services acquired by McKesson over numerous years.

Change Healthcare shares were trading up 30.67% at $23.84. The stock has a 52-week high of $24.21 and a 52-week low of $6.18.

Isoray (NYSE: ISR) shares are trading higher after the company announced it received FDA 510(k) clearance for the use of C4 Imaging's Sirius positive-signal MRI Markers with Isoray's Cesium-131, brachytherapy seeds.

Isoray designs and develops personalized brachytherapy products that provide more cost-effective cancer treatment. It is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds.

Isoray shares were trading up 207% at $1.63. The stock has a 52-week high of $2 and a 52-week low of 35 cents.

 

Related Articles (CHNG + AIKI)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com